Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate versus deferred febuxostat initiation for gout
2024-515547-34-00Phase 3Authorised
- Sponsor
- Rouen University Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of febuxostat in gout (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Number of days with gout at day 42. Planned start Aug 2023; status: authorised.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on 2024-515547-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515547-34-00.